Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care

ZIV Medical Center /ID# 226565, Safed

Shaare Zedek Medical Center /ID# 247319, Jerusalem

HaEmek Medical Center /ID# 251040, Afula

Rabin Medical Center /ID# 226568, Petah Tikva

The Chaim Sheba Medical Center /ID# 226562, Ramat Gan

Tel Aviv Sourasky Medical Center /ID# 226564, Tel Aviv

Maccabi /ID# 246679, Haifa

Duplicate_Kaplan Medical Center /ID# 226569, Rehovot

Barzilai Medical Center /ID# 229156, Ashkelon

Soroka University Medical Center /ID# 226570, Beersheba

Leumit /ID# 252029, Rehovot